John C. Reed
Director · MADRIGAL PHARMACEUTICALS, INC.
IndividualSelling only
- 2025
- Aug 18, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John C. Reed files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William John Sibold - $10.48M in MDGL purchases and sales in the last 12 months
- Kenneth Bate - $8.03M in MDGL purchases and sales in the last 12 months
- Richard S. Levy - $7.36M in MDGL purchases and sales in the last 12 months
- Mardi Dier - $3.77M in MDGL purchases and sales in the last 12 months
- Carole Huntsman - $1.71M in MDGL purchases and sales in the last 12 months
- Rebecca Taub - $1.63M in MDGL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John C. Reed?
John C. Reed is a corporate insider, tracked as Director of MADRIGAL PHARMACEUTICALS, INC. (MDGL). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John C. Reed submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John C. Reed been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($20.42M) across all tracked filings.
